Mike Raab

Michael G.
Raab is President, Chief Executive Officer & Director at Ardelyx, Inc. since 2009.
He is Chairman at TempestTx, Inc. since 2018.
He serves as Director at California Biomedical Innovation Alliance and at Tempest Therapeutics, Inc. since 2021.
He is a Member of the Governors Board at Biotechnology Innovation Organization since 2006.
Formerly, Mr. Raab was Executive Chairman at Amicus Therapeutics, Inc. from 2024 to 2026.
He was Director at Novalar Pharmaceuticals, Inc., Liquidia Technologies, Inc., ZP Opco, Inc., Hyperion Therapeutics, Inc., Cellgate, Inc., Novacea, Inc. from 2002 to 2009, and Millendo Therapeutics, Inc. He held Principal roles at Bristol Myers Squibb Co. and Repligen Corp.
He was Partner at NEA Management Co. LLC and New Enterprise Associates LLC from 2002 to 2008.
He was Senior Vice President at Therapeutics, Inc. and Senior Vice President-Therapeutics at Genzyme Corp.
from 1999 to 2002.
Mr. Raab completed undergraduate education at DePauw University in 1987.